PUCCINI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 649
EU - Europa 210
AS - Asia 63
SA - Sud America 5
OC - Oceania 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 931
Nazione #
US - Stati Uniti d'America 648
IT - Italia 97
SE - Svezia 55
IN - India 24
SG - Singapore 23
FI - Finlandia 13
UA - Ucraina 11
BG - Bulgaria 10
CN - Cina 10
DE - Germania 8
AR - Argentina 5
GB - Regno Unito 5
IE - Irlanda 3
NL - Olanda 3
PK - Pakistan 3
RO - Romania 3
AU - Australia 2
MY - Malesia 2
CA - Canada 1
EU - Europa 1
HU - Ungheria 1
RU - Federazione Russa 1
TG - Togo 1
VN - Vietnam 1
Totale 931
Città #
Fairfield 136
Woodbridge 66
Ashburn 64
Cambridge 60
Seattle 56
Houston 51
Wilmington 39
Ann Arbor 33
Rome 30
San Paolo di Civitate 16
Chandler 13
Princeton 13
Singapore 11
Plano 10
Sofia 10
Beijing 9
Lawrence 9
Boston 7
San Diego 7
Andover 6
Millbury 6
Federal 5
New York 5
Dublin 3
Helsinki 3
Jacksonville 3
Lahore 3
London 3
Milan 3
Norwalk 3
Teramo 3
Des Moines 2
Frankfurt am Main 2
Hyderabad 2
Mannheim 2
Puchong Batu Dua Belas 2
San Giuliano Terme 2
Scuola 2
Sydney 2
Berlin 1
Boardman 1
Bremen 1
Bühl 1
Cagliari 1
Cleveland 1
Dearborn 1
Den Haag 1
Edinburgh 1
Fremont 1
Hefei 1
Ho Chi Minh City 1
Lomé 1
Prato 1
Pune 1
Saronno 1
Scandicci 1
Seversk 1
Stockholm 1
Toronto 1
Trento 1
Turin 1
Voghera 1
Waterbury 1
Totale 726
Nome #
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study 149
[5ARI and PSA: open questions.] 117
The evolving picture of lower urinary tract symptom management 112
Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. 91
null 85
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice 82
EDITORIAL COMMENT to A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the beta(3) Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder 61
Variations of nighttime and daytime bladder capacity in patients with nocturia. implication for diagnosis and treatment 60
The importance of cystoscopy and bladder biopsy in women with refractory overactive bladder: the urogynaecologist's point of view? 55
null 48
THE INFLUENCE OF PHYSICAL ACTIVITY ON PROSTATE CANCER DIAGNOSIS: A BIOPSY COHORT 28
The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. 22
null 20
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 16
The management of overactive bladder: Percutaneous tibial nerve stimulation, sacral nerve stimulation, or botulinum toxin? 11
The FIGO assessment scoring system (FASS): a new holistic classification tool to assess women with pelvic floor dysfunction: validity and reliability. 7
Urinary incontinence in multiple sclerosis: Prevalence, severity and impact on patients' quality of life 7
Totale 971
Categoria #
all - tutte 2.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 5 7 29 28 36 30 33 18 15 3
2020/202196 12 4 7 6 0 3 3 8 17 16 15 5
2021/2022178 6 7 11 14 21 6 9 18 21 13 17 35
2022/2023136 27 38 12 7 8 16 4 11 7 1 4 1
2023/202498 4 10 1 12 7 25 5 3 0 11 12 8
2024/202513 3 8 2 0 0 0 0 0 0 0 0 0
Totale 971